Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents
- 1 June 2015
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 8 (7), 889-899
- https://doi.org/10.1016/j.jcin.2015.01.033
Abstract
No abstract availableKeywords
Funding Information
- Boston Scientific
- Medtronic
- Abbott Vascular
- Biotronik
- Boston Scientific
- Medtronic
This publication has 29 references indexed in Scilit:
- Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trialThe Lancet, 2015
- A Randomized Comparison of Platinum Chromium-Based Everolimus-Eluting Stents Versus Cobalt Chromium-Based Zotarolimus-Eluting Stents in All-Comers Receiving Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2014
- Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trialThe Lancet, 2013
- Drug-Eluting Coronary-Artery StentsNew England Journal of Medicine, 2013
- Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary InterventionCell Metabolism, 2012
- A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World PatientsJournal of the American College of Cardiology, 2012
- Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries: The RESOLUTE US Clinical TrialJournal of the American College of Cardiology, 2011
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary StentsNew England Journal of Medicine, 2010
- Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery DiseaseNew England Journal of Medicine, 2010
- Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trialThe Lancet, 2010